secwatch.observer — SEC 8-K summary
======================================

Issuer:     Purple Innovation, Inc. (PRPL)
CIK:        0001643953
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001213900-23-033865
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Purple Innovation appoints three new directors, terminates poison pill and PRPLS after Coliseum pact
--------------------------------------------------------------------------------

- Directors Pano Anthos and Paul Zepf resigned April 27, 2023 under Cooperation Agreement with Coliseum Capital.
- Board expanded to 8; appointed S. Hoby Darling, R. Carter Pate, and Erika Serow as directors; Adam Gray named Chair.
- Stockholder Rights Agreement (poison pill) expired early on April 27, 2023 via amendment; all Rights expired.
- All shares of Proportional Representation Preferred Linked Stock (PRPLS) redeemed and certificate eliminated.
- Special Committee formed Sept 2022 terminated; bylaws amended to reference Lead Independent Director Charter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1643953/000121390023033865/0001213900-23-033865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1643953/000121390023033865/ea177535-8k_purple.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-033865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer